Table 3.
Univariate and multivariate analyses of risk factors for death-censored allograft loss
| Variable | Patients (n) | Univariate | Multivariate | ||
|---|---|---|---|---|---|
| HR (95% CI) | P Value | HR (95% CI) | P Value | ||
| Clinicobiologic factors | |||||
| Recipient sex | |||||
| Female | 27 | 1.00 (Reference) | |||
| Male | 42 | 1.01 (0.49 to 2.08) | 0.98 | a | |
| Recipient age (per 1-yr increment) | 69 | 0.99 (0.96 to 1.01) | 0.30 | a | |
| Retransplantation | |||||
| No | 45 | 1.00 (Reference) | |||
| Yes | 24 | 1.02 (0.49 to 2.12) | 0.95 | a | |
| Donor type | |||||
| Living | 4 | 1.00 (Reference) | |||
| Deceased | 65 | 0.92 (0.22 to 3.91) | 0.91 | a | |
| Donor age (per 1-yr increment) | 69 | 1.00 (0.98 to 1.02) | 0.87 | a | |
| No. of mismatches A/B/DR | |||||
| ≤3 | 20 | 1.00 (Reference) | |||
| >3 | 49 | 0.57 (0.27 to 1.18) | 0.13 | a | |
| Cold ischemia time per 1-min increment | 69 | 1.00 (0.99 to 1.00) | 0.29 | a | |
| Estimated GFR at the time of rejectionb | |||||
| ≥30 ml/min per 1.73 m2 | 36 | 1.00 (Reference) | |||
| <30 ml/min per 1.73 m2 | 33 | 4.99 (2.12 to 11.70) | <0.001 | 3.56 (1.46 to 8.70) | 0.005 |
| Proteinuria at time of rejection | |||||
| <0.3 g/d | 32 | 1.00 (Reference) | |||
| ≥0.3 g/d | 37 | 2.82 (1.29 to 6.18) | 0.009 | — | NS |
| Histologic factorsc | |||||
| Microvascular inflammationd | |||||
| 2 or 3 | 34 | 1.00 (Reference) | |||
| ≥4 | 35 | 1.13 (0.55 to 2.35) | 0.72 | a | |
| C4d graft depositione | |||||
| 0 or 1 | 26 | 1.00 (Reference) | |||
| ≥2 | 41 | 1.45 (0.67 to 3.13) | 0.34 | a | |
| Interstitial inflammation and tubulitis | |||||
| 0 or 1 | 27 | 1.00 (Reference) | |||
| ≥2 | 42 | 0.95 (0.46 to 1.97) | 0.90 | a | |
| Transplant glomerulopathy | |||||
| 0 or 1 | 49 | 1.00 (Reference) | |||
| ≥2 | 20 | 1.24 (0.59 to 2.61) | 0.57 | a | |
| Endarteritis (vasculitis) | |||||
| 0 | 54 | 1.00 (Reference) | |||
| ≥1 | 15 | 0.92 (0.37 to 2.26) | 0.85 | a | |
| Arteriosclerosis | |||||
| 0 or 1 | 52 | 1.00 (Reference) | |||
| ≥2 | 17 | 0.72 (0.31 to 1.67) | 0.44 | a | |
| Interstitial fibrosis and tubular atrophy | |||||
| 0 or 1 | 29 | 1.00 (Reference) | |||
| ≥2 | 40 | 2.05 (0.91 to 4.62) | 0.084 | — | NS |
| Immunologic factors | |||||
| C3d-binding DSA | |||||
| No | 29 | 1.00 (Reference) | |||
| Yes | 40 | 4.35 (1.82 to 10.40) | 0.001 | 2.80 (1.12 to 6.95) | 0.027 |
| MFI of the highest DSA | |||||
| <6000 | 34 | 1.00 (Reference) | |||
| ≥6000 | 35 | 2.47 (1.17 to 5.23) | 0.018 | — | NS |
| No. of DSA | |||||
| 1 | 38 | 1.00 (Reference) | |||
| ≥2 | 31 | 1.67 (0.82 to 3.41) | 0.16 | a | |
The variables that were not tested in multivariate model.
Calculated with the Modification of Diet in Renal Disease formula.
Banff scores (0: no significant lesion, 1: mild, 2: moderate, 3: severe).
Sum of the Banff scores for glomerulitis and capillaritis.
Data missing for 2 patients. Variables at P<0.1 in univariate model were incorporated into the multivariate model.